Lithium

Lithium is a recurring medication in Emma’s psychiatric care, important not only for its intended mood-stabilizing effect but also for the way taking it makes treatment concrete: a pill must be obtained, swallowed, and lived with. Across the narrative, Emma experiences it as help that has mattered, a treatment whose effects she hopes to feel, and a reminder that recovery cannot be reduced to medication or separated neatly from questions of identity.

Use in treatment

Over two years, Emma takes psychiatric medication in various forms and accepts the accompanying side effects. Looking back on that period, she says the pills have helped: her depression feels so distant that she can scarcely imagine it, and she describes her energy as returned. Lithium is part of the regimen she takes during this period. In a scene framed as her last day of psychiatric care, she goes to the hospital pharmacy for her final prescriptions before an appointment with her psychiatrist. She regards the trip as the end of collecting medication and feels well enough to imagine that she is ready to take charge again.

That sense of completion is not the only account of Lithium in the book. Other scenes show Emma taking it during an admission to the PAAZ, alongside Tegretol. Rajid Panjani proposes adding Tegretol to strengthen Lithium’s mood-stabilizing effect; because Emma is already taking Lithium at her current dose, he says that the additional medication might begin to work within a few days. The combination is offered as a way to help while the clinicians consider whether a bipolar diagnosis could explain her difficulties. Thus Lithium belongs to an ongoing clinical process, not simply to the apparent endpoint of the pharmacy visit.

The pharmacy and the pill

The pharmacy scene makes the treatment’s dependence on ordinary supply visible. On Emma’s final visit, an assistant tells her there is not enough Lithium in stock to provide everything at once. She can take a strip of ten pills and return for the remainder in two days, or obtain a repeat prescription to try at her own pharmacy. The shortage produces a sudden flicker of panic, which Emma quickly pushes aside; she asks for the prescription, and the assistant later slides a stack of boxes across the counter with the repeat prescription on top.

The small practical interruption presses against Emma’s expansive confidence. She closes her bag with the pills and prescription inside and thinks that she has what she needs, even that she would manage if she did not. She is looking toward freedom and her last psychiatric appointment, but the medication still has to be collected, counted, and carried. The episode gives Lithium material presence in the narrative: treatment depends not only on a decision to take a drug but also on stock, prescriptions, and access.

Taking Lithium amid fear and uncertainty

During the PAAZ admission, Lithium is presented alongside the newly added Tegretol. When Gwen places the two blister strips before Emma to check, Emma recognizes one as familiar and the other as new. The situation strikes her as strange: she is in hospital because she has wanted to take too many pills, and now she is being given another one. She swallows the tablets with water, tastes the familiar metallic bitterness she associates with Lithium and the plastic cup, and finds herself overwhelmed by anger and despair. She says that she is frightened by the new diagnosis, new pills, and possible side effects.

Gwen reassures her that the staff will watch her closely and that a diagnosis, if confirmed, could help them provide better care. Emma does not know whether the day has really gone well. The physical side effects have been limited, but her inner sense of direction has faltered; she feels as though she has lost the instructions for how to live with what is happening. She tells Gwen that she simply wishes Lithium would work. Gwen answers that she wishes that too, while adding that everyone sometimes needs help. Emma cannot tell whether Gwen means the medication or Emma herself. Their exchange leaves the desired effect unresolved: Lithium is something Emma depends on and hopes for, but hope does not make her experience of treatment straightforward.

Medication, identity, and other people’s meanings

Lithium also enters the book through questions about what treatment might take away. In conversation with Beatrice, Emma is asked whether she feared that new pills would change her or make her lose herself. Emma recalls that, on her first admission to the PAAZ, she felt she had little choice about taking medication, voluntarily or involuntarily. Her deeper fear, as she remembers it, was not simply losing her identity to a drug. Depression, though an enemy, was familiar; she wondered what would remain if it were removed, and how anyone could distinguish the sick part from the self.

Beatrice’s account complicates any easy assumption that medication has one meaning for every patient. She says that after taking pills for the first time, she stopped feeling God’s presence, and that this loss contributed to her leaving hospital and later returning. The conversation does not establish that Lithium alone caused her experience. Instead, it places Emma’s medication questions beside Beatrice’s account of faith and depression, showing how treatment can be interpreted through deeply personal understandings of what makes a life recognizable.

Emma likewise resists reducing her distress to a medication list or diagnostic label. She describes hallucinations and delusions not only by naming what she sees or believes, but by emphasizing the shock, fear, and disorientation when familiar reality seems to have shifted. In discussing that experience with Lars, she uses the vanished television guide as an image for the distress of repeatedly losing confidence in what is real. The narrative’s attention to this account gives context to her treatment: Lithium may be prescribed to address mood, but Emma’s suffering also includes experiences that demand listening and explanation.

Recurrence and the limits of a cure narrative

The apparent farewell to psychiatric care sits in tension with scenes of renewed distress and treatment. Emma’s confidence on the last pharmacy visit, when she feels better and imagines pill collection as finished, is not presented as proof that future difficulty has become impossible. Elsewhere she describes depression returning, remembers a suicidal conviction that had seemed to her less like a plan than an unquestionable necessity, and encounters the limits of what other people can see. In a later exchange with Sergei, she insists that worsening may happen again even as she asks him to let her go. These episodes make the book’s account of recovery recurrent rather than a simple passage from illness to cure.

Lithium’s significance lies in that unresolved balance. Emma can recognize that medication has helped and still feel anger, fear, or uncertainty while taking it; she can hope it will work without claiming that it explains every part of her experience. Its tablets link clinical decisions to the pharmacy counter, the hospital routine, family relationships, and Emma’s changing account of who she is. The narrative neither dismisses that practical support nor lets it stand in for the work of living with recurring illness.